Valuation: Albert David Limited

Market Cap 3.96B 41.3M 36.29M 33.88M 31.09M 58.2M 59.63M 402M 157M 1.96B 155M 152M 6.77B P/E 2025
26.9x
P/E 2026 -224x
Enterprise Value 1.68B 17.5M 15.38M 14.35M 13.17M 24.66M 25.27M 170M 66.56M 829M 65.7M 64.28M 2.87B EV / Sales 2025
0.67x
EV / Sales 2026 0.32x
Free-Float
35.96%
Yield 2025
0.62%
Yield 2026 0.85%
1 day+0.31%
1 week-1.08%
Current month-1.50%
1 month-2.79%
3 months-4.37%
6 months-2.12%
Current year-6.50%
1 week 678
Extreme 678
702.95
1 month 678
Extreme 678
723
Current year 579.9
Extreme 579.9
819.6
1 year 579.9
Extreme 579.9
918.8
3 years 579.9
Extreme 579.9
1,753.95
5 years 486.85
Extreme 486.85
1,753.95
10 years 263
Extreme 263
1,753.95
Manager TitleAgeSince
Chief Executive Officer 52 12/05/2026
Director of Finance/CFO - 01/12/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 73 30/12/2009
Director/Board Member 68 31/03/2014
Director/Board Member 64 24/08/2020
Change 5-day change 1-year change 3-year change Capi.($)
+0.31%-1.08% - - 41.34M
+0.67%+1.43%+16.90%+74.77% 49.64B
+1.05%+3.84%+64.12%+113.57% 36.54B
+2.06%+2.92%-6.22%+25.17% 12.22B
+2.14%-1.78%+14.55%+75.28% 11.48B
+1.05%+1.16%+31.33%+131.86% 9.04B
+3.08%+3.94%+50.54%-4.41% 6.94B
+0.17%-0.34%+12.61%+31.76% 6.74B
+3.53%+0.87%+5.47%+183.15% 6.45B
+0.61%-6.24%-32.70%-1.66% 5.42B
Average +1.47%-0.74%+17.40%+69.94% 16.05B
Weighted average by Cap. +1.24%+0.45%+26.65%+80.17%

Financials

2025 2026
Net sales 3.46B 36.1M 31.72M 29.61M 27.17M 50.87M 52.12M 351M 137M 1.71B 136M 133M 5.91B 3.34B 34.83M 30.6M 28.57M 26.22M 49.08M 50.29M 339M 132M 1.65B 131M 128M 5.71B
Net income 172M 1.8M 1.58M 1.47M 1.35M 2.53M 2.59M 17.47M 6.83M 85.12M 6.74M 6.6M 294M -14.95M -156K -137K -128K -117K -220K -225K -1.52M -594K -7.4M -586K -573K -25.57M
Net Debt -2.31B -24.15M -21.22M -19.81M -18.18M -34.03M -34.87M -235M -91.87M -1.14B -90.68M -88.71M -3.96B -2.28B -23.8M -20.92M -19.52M -17.92M -33.54M -34.37M -232M -90.54M -1.13B -89.37M -87.43M -3.9B
Logo Albert David Limited
Albert David Limited is an India-based pharmaceutical company. The Company's principal business is manufacturing and trading of pharmaceutical formulations, infusion solutions, herbal dosage forms and bulk drugs by way of domestic sale or export. Its product categories include formulations and bulk drugs. Its product range includes Placentrex range, Anaflam range and BREAZE range. Its formulations include parenteral, oral/enteral, topical agents and vision care. Its parenteral categories include amino acids infusion, anti-microbial, anti-leishmaniasis (kalazar), haemostat (inj), lvp, neurotropic vitamin and placenta extract. The Company's oral/enteral categories include amino acids oral, anthelmintic, anti-microbial, anti-ulcer ants, anti-vertigo, appetite stimulants, anti-tubercular, expectorant / cough syrup, hematinic, haemostat, hepato protective (ayurveda) and hepato protective (others). Its vision care categories include anti glaucoma, anti-infective and NSAID.
Employees
1,476
Date Price Change Volume
29/07/26 INR 688.75 +0.31% 2,407
28/07/26 INR 686.65 +0.35% 692
27/07/26 INR 684.25 -2.02% 1,714
24/07/26 INR 698.35 +2.17% 1,133
23/07/26 INR 683.55 -0.57% 3,881